The latest closing stock price for AN2 Therapeutics as of June 13, 2025 is 1.07.
An investor who bought $1,000 worth of AN2 Therapeutics stock at the IPO in 2022 would have $-931 today, roughly -1 times their original investment - a -58.89% compound annual growth rate over 3 years.
The all-time high AN2 Therapeutics stock closing price was 22.29 on August 15, 2022.
The AN2 Therapeutics 52-week high stock price is 3.07, which is 186.9% above the current share price.
The AN2 Therapeutics 52-week low stock price is 0.87, which is 18.7% below the current share price.
The average AN2 Therapeutics stock price for the last 52 weeks is 1.39.
An investor who bought $1,000 worth of AN2 Therapeutics stock at the IPO in 2022 would have $-931 today, roughly -1 times their original investment - a -58.89% compound annual growth rate over 3 years.
The all-time high AN2 Therapeutics stock closing price was 22.29 on August 15, 2022.
The AN2 Therapeutics 52-week high stock price is 3.07, which is 186.9% above the current share price.
The AN2 Therapeutics 52-week low stock price is 0.87, which is 18.7% below the current share price.
The average AN2 Therapeutics stock price for the last 52 weeks is 1.39.